| Antipsychotics and mortality in a nationwide cohort of 823 patients with schizophrenia |
35 |
| Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response |
34 |
| Mindfulness- and acceptance-based interventions for psychosis: Our current understanding and a meta-analysis |
29 |
| Metacognition - What did James H. Flavell really say and the implications for the conceptualization and design of metacognitive interventions |
27 |
| Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study |
27 |
| Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review |
25 |
| Elevated clozapine levels associated with infection: A systematic review |
22 |
| The use of polygenic risk scores to identify phenotypes associated with genetic risk of schizophrenia: Systematic review |
21 |
| Metacognitive Reflection and Insight Therapy for Early Psychosis: A preliminary study of a novel integrative psychotherapy |
21 |
| The link between schizophrenia and substance use disorder: A unifying hypothesis |
20 |
| Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects |
19 |
| Multiple retinal anomalies in schizophrenia |
18 |
| A systematic review of metabolite biomarkers of schizophrenia |
17 |
| Prescriber and institutional barriers and facilitators of clozapine use: A systematic review |
17 |
| Changes in metabolism and microbiota after 24-week risperidone treatment in drug naive, normal weight patients with first episode schizophrenia |
17 |
| Cause-specific life years lost among persons diagnosed with schizophrenia: Is it getting better or worse? |
17 |
| Relationship of common variants in CHRNA5 with early-onset schizophrenia and executive function |
17 |
| Enhancing social functioning in young people at Ultra High Risk (UHR) for psychosis: A pilot study of a novel strengths and mindfulness-based online social therapy |
17 |
| TNF-alpha and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia |
17 |
| Altered gyrification in schizophrenia and its relation to other morphometric markers |
16 |
| Environmental adversities and psychotic symptoms: The impact of timing of trauma, abuse, and neglect |
15 |
| Elevated hair cortisol is associated with childhood maltreatment and cognitive impairment in schizophrenia and in bipolar disorders |
15 |
| Mediating role of aberrant salience and self-disturbances for the relationship between childhood trauma and psychotic-like experiences in the general population |
15 |
| Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: A pilot clinical trial |
15 |
| Development and psychometric properties of the Multidimensional Schizotypy Scale: A new measure for assessing positive, negative, and disorganized schizotypy |
15 |
| Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders |
15 |
| Is it possible for people with severe mental illness to sit less and move more? A systematic review of interventions to increase physical activity or reduce sedentary behaviour |
14 |
| Clinical and functional long-term outcome of patients at clinical high risk (CHR) for psychosis without transition to psychosis: A systematic review |
14 |
| Premature mortality among people with severe mental illness - New evidence from linked primary care data |
14 |
| Treatment of social cognition in schizophrenia: Current status and future directions |
14 |
| A systematic review and discussion of symptom specific cognitive behavioural approaches to delusions and hallucinations |
14 |
| Non-invasive brain stimulation for negative symptoms in schizophrenia: An updated systematic review and meta-analysis |
14 |
| Depression during first episode psychosis and subsequent suicide risk: A systematic review and meta-analysis of longitudinal studies |
14 |
| Do trauma-focussed psychological interventions have an effect on psychotic symptoms? A systematic review and meta-analysis |
14 |
| A widening longevity gap between people with schizophrenia and general population: A literature review and call for action |
13 |
| The complex relationship between self-reported 'personal recovery' and clinical recovery in schizophrenia |
13 |
| Abnormal regional homogeneity as a potential imaging biomarker for adolescent-onset schizophrenia: A resting-state fMRI study and support vector machine analysis |
13 |
| Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis |
13 |
| Is formal thought disorder in schizophrenia related to structural and functional aberrations in the language network? A systematic review of neuroimaging findings |
13 |
| Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension |
13 |
| Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia |
13 |
| Brief assessment of schizotypal traits: A multinational study |
12 |
| Dietary patterns and physical activity in people with schizophrenia and increased waist circumference |
12 |
| The incidence rate of cancer in patients with schizophrenia: A meta-analysis of cohort studies |
12 |
| Role of frontal white matter and corpus callosum on social function in schizophrenia |
12 |
| Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review |
12 |
| Allostatic load index and its clinical correlates at various stages of psychosis |
12 |
| Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia |
12 |
| Cognitive and functional deficits in people with schizophrenia: Evidence for accelerated or exaggerated aging? |
11 |
| Childhood trauma and clinical high risk for psychosis |
11 |
